Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 111

    1.

    HIV infection and the risk of cancers with and without a known infectious cause.

    Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, Klein D, Quesenberry CP Jr, Towner WJ, Abrams DI.

    AIDS. 2009 Nov 13;23(17):2337-45.PMID: 19741479 [PubMed - in process]Related articles

    2.

    Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals.

    Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S.

    J Soc Integr Oncol. 2009 Summer;7(3):85-120. No abstract available. PMID: 19706235 [PubMed - in process]Related articles

    3.

    Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

    Silverberg MJ, Abrams DI.

    Curr Opin HIV AIDS. 2009 Jan;4(1):42-51.PMID: 19339938 [PubMed - indexed for MEDLINE]Related articles

    4.

    Nausea at the end of adjuvant cancer treatment in relation to exercise during treatment in patients with breast cancer.

    Lee J, Dodd MJ, Dibble SL, Abrams DI.

    Oncol Nurs Forum. 2008 Sep;35(5):830-5.PMID: 18765330 [PubMed - indexed for MEDLINE]Related articles

    5.

    Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.

    Baker JV, Peng G, Rapkin J, Krason D, Reilly C, Cavert WP, Abrams DI, MacArthur RD, Henry K, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

    J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):541-6.PMID: 18645520 [PubMed - indexed for MEDLINE]Related articles

    6.

    CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

    Baker JV, Peng G, Rapkin J, Abrams DI, Silverberg MJ, MacArthur RD, Cavert WP, Henry WK, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

    AIDS. 2008 Apr 23;22(7):841-8.PMID: 18427202 [PubMed - indexed for MEDLINE]Related articles

    7.

    AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.

    Silverberg MJ, Abrams DI.

    Curr Opin Oncol. 2007 Sep;19(5):446-51. Review.PMID: 17762569 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk of cancers during interrupted antiretroviral therapy in the SMART study.

    Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI.

    AIDS. 2007 Sep 12;21(14):1957-63.PMID: 17721103 [PubMed - indexed for MEDLINE]Related articles

    9.

    Vaporization as a smokeless cannabis delivery system: a pilot study.

    Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL.

    Clin Pharmacol Ther. 2007 Nov;82(5):572-8. Epub 2007 Apr 11.PMID: 17429350 [PubMed - indexed for MEDLINE]Related articles

    10.

    An overview of integrative oncology.

    Abrams DI.

    Clin Adv Hematol Oncol. 2007 Jan;5(1):45-7. No abstract available. PMID: 17339827 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.

    Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL.

    Neurology. 2007 Feb 13;68(7):515-21.PMID: 17296917 [PubMed - indexed for MEDLINE]Related articles

    12.

    Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study.

    Abrams DI, Shade SB, Couey P, McCune JM, Lo J, Bacchetti P, Chang B, Epling L, Liegler T, Grant RM.

    AIDS Res Hum Retroviruses. 2007 Jan;23(1):77-85.PMID: 17263636 [PubMed - indexed for MEDLINE]Related articles

    13.

    The efficacy of distant healing for human immunodeficiency virus--results of a randomized trial.

    Astin JA, Stone J, Abrams DI, Moore DH, Couey P, Buscemi R, Targ E.

    Altern Ther Health Med. 2006 Nov-Dec;12(6):36-41.PMID: 17131980 [PubMed - indexed for MEDLINE]Related articles

    14.

    Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 study.

    Lawrence J, Hullsiek KH, Thackeray LM, Abrams DI, Crane LR, Mayers DL, Jones MC, Saldanha JM, Schmetter BS, Baxter JD.

    J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):169-78.PMID: 16951642 [PubMed - indexed for MEDLINE]Related articles

    15.

    Community-based clinical trials in hiv: the contributions of Mathilde Krim.

    Abrams DI.

    AIDS Patient Care STDS. 2006 Jul;20(7):480-5. No abstract available. PMID: 16839246 [PubMed - indexed for MEDLINE]Related articles

    16.

    Contrasts, conflicts, and change: A case in cultural oncology.

    Dhruva A, Cheng J, Kwong M, Luce JA, Abrams DI.

    J Support Oncol. 2006 Jun;4(6):301-4. No abstract available. PMID: 16805333 [PubMed - indexed for MEDLINE]Related articles

    17.

    Medicinal cannabis: rational guidelines for dosing.

    Carter GT, Weydt P, Kyashna-Tocha M, Abrams DI.

    IDrugs. 2004 May;7(5):464-70. Review.PMID: 15154108 [PubMed - indexed for MEDLINE]Related articles

    18.

    Nadir CD4+ T cell count predicts response to subcutaneous recombinant interleukin-2.

    Markowitz N, Bebchuk JD, Abrams DI; Terry Beirn Community Program for Clinical Research on AIDS.

    Clin Infect Dis. 2003 Oct 15;37(8):e115-20. Epub 2003 Sep 24.PMID: 14523786 [PubMed - indexed for MEDLINE]Related articles

    19.

    Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial.

    Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M.

    Ann Intern Med. 2003 Aug 19;139(4):258-66.PMID: 12965981 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

    Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, Kitahata MM, Krone M, Neilands TB, Brand RJ, Lederman MM, Martin JN.

    AIDS. 2003 Sep 5;17(13):1907-15.PMID: 12960823 [PubMed - indexed for MEDLINE]Related articles

    21.

    Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus.

    Lawrence J, Mayers DL, Hullsiek KH, Collins G, Abrams DI, Reisler RB, Crane LR, Schmetter BS, Dionne TJ, Saldanha JM, Jones MC, Baxter JD; 064 Study Team of the Terry Beirn Community Programs for Clinical Research on AIDS.

    N Engl J Med. 2003 Aug 28;349(9):837-46.PMID: 12944569 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients.

    Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI.

    J Clin Pharmacol. 2002 Nov;42(11 Suppl):82S-89S.PMID: 12412840 [PubMed - indexed for MEDLINE]Related articles

    23.

    Associations between water-treatment methods and diarrhoea in HIV-positive individuals.

    Eisenberg JN, Wade TJ, Hubbard A, Abrams DI, Leiser RJ, Charles S, Vu M, Saha S, Wright CC, Levy DA, Jensen P, Colford JM Jr.

    Epidemiol Infect. 2002 Oct;129(2):315-23.PMID: 12405100 [PubMed - indexed for MEDLINE]Related articles

    24.

    The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT.

    Emery S, Abrams DI, Cooper DA, Darbyshire JH, Lane HC, Lundgren JD, Neaton JD; ESPRIT Study Group.

    Control Clin Trials. 2002 Apr;23(2):198-220.PMID: 11943448 [PubMed - indexed for MEDLINE]Related articles

    25.

    Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059.

    Abrams DI, Bebchuk JD, Denning ET, Davey RT, Fox L, Lane HC, Sampson J, Verheggen R, Zeh D, Markowitz NP; Terry Beirn Community Programs for Clinical Research on AIDS.

    J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):221-31.PMID: 11873071 [PubMed - indexed for MEDLINE]Related articles

    26.

    The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir.

    Kosel BW, Aweeka FT, Benowitz NL, Shade SB, Hilton JF, Lizak PS, Abrams DI.

    AIDS. 2002 Mar 8;16(4):543-50.PMID: 11872997 [PubMed - indexed for MEDLINE]Related articles

    27.

    Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy.

    Mulligan K, Tai VW, Algren H, Abrams DI, Leiser RJ, Lo JC, Schambelan M.

    J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):443-8.PMID: 11391163 [PubMed - indexed for MEDLINE]Related articles

    28.

    Potential interventions for HIV/AIDS wasting: an overview.

    Abrams DI.

    J Acquir Immune Defic Syndr. 2000 Oct 1;25 Suppl 1:S74-80. Review.PMID: 11126431 [PubMed - indexed for MEDLINE]Related articles

    29.

    Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life.

    Abrams DI, Steinhart C, Frascino R.

    Int J STD AIDS. 2000 Oct;11(10):659-65.PMID: 11057937 [PubMed - indexed for MEDLINE]Related articles

    30.

    A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

    Baxter JD, Mayers DL, Wentworth DN, Neaton JD, Hoover ML, Winters MA, Mannheimer SB, Thompson MA, Abrams DI, Brizz BJ, Ioannidis JP, Merigan TC.

    AIDS. 2000 Jun 16;14(9):F83-93.PMID: 10894268 [PubMed - indexed for MEDLINE]Related articles

    31.

    Use of a chinese herbal medicine for treatment of hiv-associated pathogen-negative diarrhea.

    Cohen MR, Mitchell TF, Bacchetti P, Child C, Crawford S, Gaeddert A, Abrams DI.

    Integr Med. 2000 Mar 21;2(2):79-84.PMID: 10882880 [PubMed - as supplied by publisher]Related articles

    32.

    Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS.

    Eberly LE, Ohman PA, Neaton JD, Price RW, Abrams DI.

    AIDS. 2000 May 26;14(8):995-1000.PMID: 10853981 [PubMed - indexed for MEDLINE]Related articles

    33.

    Clinical experience and choice of drug therapy for human immunodeficiency virus disease.

    Brosgart CL, Mitchell TF, Coleman RL, Dyner T, Stephenson KE, Abrams DI.

    Clin Infect Dis. 1999 Jan;28(1):14-22.PMID: 10028063 [PubMed - indexed for MEDLINE]Related articles

    34.

    Getting on with AIDS.

    Abrams DI.

    Lancet. 1999 Jan 30;353(9150):415. No abstract available. PMID: 9950484 [PubMed - indexed for MEDLINE]Related articles

    35.

    Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS.

    Cox LE, Rouff JR, Svendsen KH, Markowitz M, Abrams DI.

    Health Soc Work. 1998 Nov;23(4):290-7.PMID: 9834882 [PubMed - indexed for MEDLINE]Related articles

    36.

    Medical marijuana: tribulations and trials.

    Abrams DI.

    J Psychoactive Drugs. 1998 Apr-Jun;30(2):163-9.PMID: 9692378 [PubMed - indexed for MEDLINE]Related articles

    37.

    Not all is dead in HIV-1 graveyard.

    Grant RM, Abrams DI.

    Lancet. 1998 Jan 31;351(9099):308-9. No abstract available. PMID: 9652607 [PubMed - indexed for MEDLINE]Related articles

    38.

    Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS.

    Wheeler DA, Gibert CL, Launer CA, Muurahainen N, Elion RA, Abrams DI, Bartsch GE.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998 May 1;18(1):80-5.PMID: 9593462 [PubMed - indexed for MEDLINE]Related articles

    39.

    A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS.

    Brosgart CL, Louis TA, Hillman DW, Craig CP, Alston B, Fisher E, Abrams DI, Luskin-Hawk RL, Sampson JH, Ward DJ, Thompson MA, Torres RA.

    AIDS. 1998 Feb 12;12(3):269-77.PMID: 9517989 [PubMed - indexed for MEDLINE]Related articles

    40.

    Nurses' attitudes and beliefs toward assisted suicide in AIDS.

    Leiser RJ, Mitchell TF, Hahn J, Slome L, Abrams DI.

    J Assoc Nurses AIDS Care. 1998 Mar-Apr;9(2):26-33.PMID: 9513133 [PubMed - indexed for MEDLINE]Related articles

    41.

    Genotypic-resistance assays and antiretroviral therapy.

    Deeks SG, Abrams DI.

    Lancet. 1997 May 24;349(9064):1489-90. No abstract available. PMID: 9167453 [PubMed - indexed for MEDLINE]Related articles

    42.

    Physician-assisted suicide and patients with human immunodeficiency virus disease.

    Slome LR, Mitchell TF, Charlebois E, Benevedes JM, Abrams DI.

    N Engl J Med. 1997 Feb 6;336(6):417-21.PMID: 9010149 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    The role of critical care nurses in euthanasia and assisted suicide.

    Leiser RJ, Mitchell TF, Hahn JA, Abrams DI.

    N Engl J Med. 1996 Sep 26;335(13):972-3; author reply 973-4. No abstract available. PMID: 8786782 [PubMed - indexed for MEDLINE]Related articles

    44.

    Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms.

    Burack JH, Cohen MR, Hahn JA, Abrams DI.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):386-93.PMID: 8673548 [PubMed - indexed for MEDLINE]Related articles

    45.

    Current therapeutic options for Kaposi's sarcoma.

    Abrams DI.

    Oncology (Williston Park). 1996 Jun;10(6 Suppl):24-7; discussion 37-8. Review.PMID: 16871706 [PubMed - indexed for MEDLINE]Related articles

    46.

    Off-label drug use in human immunodeficiency virus disease.

    Brosgart CL, Mitchell T, Charlebois E, Coleman R, Mehalko S, Young J, Abrams DI.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 1;12(1):56-62.PMID: 8624761 [PubMed - indexed for MEDLINE]Related articles

    47.

    Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection.

    Goldman AI, Carlin BP, Crane LR, Launer C, Korvick JA, Deyton L, Abrams DI.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1;11(2):161-9.PMID: 8556398 [PubMed - indexed for MEDLINE]Related articles

    48.

    Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura.

    Northfelt DW, Charlebois ED, Mirda MI, Child C, Kaplan LD, Abrams DI.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):45-50.PMID: 8548345 [PubMed - indexed for MEDLINE]Related articles

    49.

    Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

    Neaton JD, Wentworth DN, Rhame F, Hogan C, Abrams DI, Deyton L.

    Stat Med. 1994 Oct 15-30;13(19-20):2107-25. Review.PMID: 7846414 [PubMed - indexed for MEDLINE]Related articles

    50.

    Treatment options in zidovudine intolerance or failure.

    Abrams DI.

    AIDS. 1994 Sep;8 Suppl 3:S3-7.PMID: 7840914 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...